IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 217 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71,604 | -37.7% | 16,200 | 0.0% | 0.02% | -40.0% |
| Q2 2023 | $115,020 | +11.1% | 16,200 | 0.0% | 0.02% | -35.9% |
| Q4 2022 | $103,519 | -31.9% | 16,200 | 0.0% | 0.04% | +5.4% |
| Q3 2022 | $152,000 | -18.3% | 16,200 | 0.0% | 0.04% | -9.8% |
| Q2 2022 | $186,000 | -65.5% | 16,200 | -50.0% | 0.04% | -61.0% |
| Q1 2022 | $539,000 | +73.9% | 32,400 | +100.0% | 0.10% | +94.4% |
| Q4 2021 | $310,000 | -28.4% | 16,200 | 0.0% | 0.05% | -31.6% |
| Q3 2021 | $433,000 | +4.3% | 16,200 | 0.0% | 0.08% | -2.5% |
| Q2 2021 | $415,000 | -17.3% | 16,200 | 0.0% | 0.08% | -23.6% |
| Q1 2021 | $502,000 | -38.8% | 16,200 | 0.0% | 0.11% | -43.3% |
| Q4 2020 | $820,000 | +58.3% | 16,200 | 0.0% | 0.19% | +32.6% |
| Q3 2020 | $518,000 | – | 16,200 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |